SA scheme opposes a rise in country’s SEP

South African body the Health Funders Association (HFA), which represents local stakeholders involved in funding private healthcare, has announced strong opposition to “any interim increase in medicine costs this year”. This comes in the wake of lobbying of government by industry for a further increase in the 2018 single exit price (SEP).  

More from Drug Pricing

More from Policy & Regulation